Abstract
A simple and stability indicating reverse-phase high-performance liquid chromatographic method for the simultaneous analysis of ruscogenin, neoruscogenin, trimebutine, and parabens including methylparaben and propylparaben has been developed and validated. The separations were performed using a C18 column (250 × 4.6 mm, 5 μm i.d.). The column temperature was set to 25 °C. The mobile phase consisted of acetonitrile (mobile phase B) and 20 mM phosphate buffer pH 3.9 (mobile phase A) and was mixed in gradient elution mode using a binary pump. The developed method was validated according to the requirements of the ICH Q2(R2) guideline. In all cases, the method was found selective for all active substances and parabens. The limit of detection and limit of quantification values ranged from 0.02 to 0.45 µg mL–1 and from 0.06 to 1.35 µg mL–1, respectively. The intraday and interday accuracy (relative error ≤ 1.89) and precision (relative standard deviation ≤ 1.99) values of the method for all compounds were found in the limits. Based on the validation studies, the developed method was found to be selective (peak purity index ≥ 0.9904), sensitive, accurate, precise, and robust. The developed method was successfully applied for the quantification of Ruscogenin, neoruscogenin, trimebutine and methylparaben, propylparaben from the semi-solid dosage form.
Similar content being viewed by others
Availability of Data and Materials
There are no restrictions for researchers to access the datasets used in the article.
References
Shafik A (2009) Surgical anatomy of hemorrhoids. Surgical treatment of hemorrhoids. Springer, London
Dennison A, Paraskevopoulos J, Kerrigan D, Shorthouse A (1996) Minerva Chir 51:209–216
Lohsiriwat V (2012) World J Gastroenterol WJG 18:2009
Higuero T, Abramowitz L, Castinel A, Fathallah N, Hemery P, Duhoux CL, Pigot F, Pillant-Le Moult H, Senéjoux A, Siproudhis L (2016) J Visc Surg 153:213–218
Ercan G, Tartar RI, Solmaz A, Gulcicek OB, Karagulle OO, Meric S, Cayoren H, Kusaslan R, Kemik A, Kayali DG (2020) Asian J Surg 43:405–416
Nazemiyeh H, Zengin G, Mehrad H, Farhoudi M, Bahadori MB (2020) Eur J Integr Med 40:101245
Fu F, Lai Q, Hu J, Zhang L, Zhu X, Kou J, Yu B, Li F (2022) Antioxidants 11:583
Hua H, Zhu Y, Song Y-H (2018) Biomed Pharmacother 101:115–122
Wu Y, Wang Y, Gong S, Tang J, Zhang J, Li F, Yu B, Zhang Y, Kou J (2020) Biomed Pharmacother 125:109868
He J, Wang Y, Xu L, Xu C, Zhu Y, Xu M, Chen Y, Guo L, Hu W, Xu D (2022) Evid-Based Complement Altern Med 2022:6425121
Wang Y-w, Wu Y-h, Zhang J-z, Tang J-h, Fan R-p, Li F, Yu B-y, Kou J-p, Zhang Y-Y (2021) Acta Pharmacol Sin 42:726–734
Salvioli B (2019) Minerva Gastroenterol Dietol 65:229–238
Fan Y-p, Liu P, Xue W-k, Zhao W-j, Pan H-c (2018) Front Pharmacol 9:664
Kountouras J, Gavalas E, Papaefthymiou A, Tsechelidis I, Polyzos SA, Bor S, Diculescu M, Jadallah Κ, Tadeusz M, Karakan T (2020) Medicina 56:339
Nakajima S, Ogawa N, Yokoue N, Tachibana H, Tamada K, Okazawa M, Sato A, Oyama T, Abe H, Kamiya T (2020) Biochem Biophys Res Commun 533:1155–1161
Lee H, Kwon O-B, Lee J-E, Jeon Y-H, Lee D-S, Min S-H, Kim J-W (2021) Cells 10:918
Güvenç A, Şatır E, Coşkun M (2007) Chromatographia 66:141–145
Nikolov S, Joneidi M, Panova D (1976) Pharmazie 31:611–612
Ding R, Di T-y, Wang G-l, Lin R-c, Liu L-f (2011) Chin J PharmAnal 31:127–130
Ji P-y, Li Z-w, Yang Q, Wu R (2015) J Chromatogr B 985:71–74
Zhang H, Xu T, Gao L, Liu X, Liu J, Yu B (2017) Molecules 22:1250
Huang B, Yao C, Bian Q, Wang Z, Mo J (2011) Yao xue xue bao Acta Pharm Sin 46:443–446
Lavit M, Saivin S, Boudra H, Michel F, Martin A, Cahiez G, Labaune JP, Chomard JM, Houin G (2000) Arzneimittelforschung 50:640–644
Joo E-H, Chang W-I, Oh I, Shin S-C, Na H-K, Lee Y-B (1999) J Chromatogr B Biomed Sci Appl 723:239–246
El-Gindy A, Emara S, Hadad GM (2003) J Pharm Biomed Anal 33:231–241
Zaitsev VN, Syrotchuk OA, Didukh IR (2015) J Chem Pharm Res 7:609–615
Lin Z-h, Song M (2001) Chin J Pharm Anal 21:25–27
Wang W, Zuo W-j (2003) Chin J Pharm Anal 23:111–113
Larabi IA, Duverneuil-Mayer C, Abe E, Baud F, Alvarez J-C (2015) J Anal Toxicol 39:720–725
Mostafa AMS, Ahmad AB (1999) Bull Fac Pharm-Cairo Univ 37(3):175–180
Wang H, Zhou H, Horimoto S, Jiang J, Mayumi T, Hu P (2002) J Chromatogr B 779:173–187
Qin Y, Zhao H, Zhang W, Zhao N, Fan P, Zhang L, Zhang H (2013) Life Sci J 10:2840–2849
Yang Z-d, Zhang Q, Ma B, Hu Y-y, Zheng Y-y, Wang Y-l (2012) Chin J Pharm Anal 32:1351–1356
Lee S-H, Lee J-H, Cho S, Do S-H, Woo Y-A (2012) Arch Pharmacal Res 35:1599–1607
Ayad M, El-Balkiny M, Hosny M, Metias Y (2016) Indian J Adv Chem Sci 4:85–97
Abdel-Wadood HM (2002) Bull Pharm Sci Assiut 25:137–144
Shaban M (2002) Sci Pharm 70:341–351
Walash M, El Abass SA, Fathy M (2018) Anal Methods 10:4511–4517
Adhoum N, Monser L (2005) J Pharm Biomed Anal 38:619–623
Li F, Yu L (2001) Biomed Chromatogr 15:248–251
Elqudaby H, Mohamed GG, El Din GM (2014) Int J Electrochem Sci 9:856–869
Elqudaby HM, Mohamed GG, El Din GM (2013) J Pharm Res 7:686–691
Ayad M, El-Balkiny M, Hosny M, Metias Y (2016) Indian J Adv Chem Sci 4:149–159
Yu L, Li F (2001) Yao xue xue bao Acta Pharm Sin 36:131–133
Ali TA, Mohamed GG, El-Sonbati AZ, Diab MA, Elkfass AM (2020) Iran J Pharm Res IJPR 19:533
Rasool N, Kanwal Q, Waseem M, Khan MI (2021) Biomed Chromatogr 35:e4997
Corradini D (2016) Handbook of HPLC. CRC Press
Guideline IHT (2005) Q2 (R1) 1:05
Funding
No financial support was received from any institution in this study.
Author information
Authors and Affiliations
Contributions
GÖ: conceptualization, methodology, formal analysis, writing—original draft, visualization, writing—review & editing. EN: conceptualization, supervision, methodology, visualization, writing—review & editing.
Corresponding author
Ethics declarations
Conflict of Interest
This manuscript has not been submitted to, nor is under review at, another journal or other publishing venue. The authors have no affiliation with any organization with a direct or indirect financial interest in the subject matter discussed in the manuscript.
Ethical Approval
Ethical approval is not required as we did not use animals, humans or blood cells in our study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Özen, G., Nemutlu, E. Simultaneous Determination of Ruscogenin, Neoruscogenin, Trimebutin, and Parabens in Cream Formulation by Reverse Phase High Performance Liquid Chromatography. Chromatographia 86, 649–657 (2023). https://doi.org/10.1007/s10337-023-04282-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-023-04282-z